The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Axios Visuals Louisiana women are more likely to be prescribed GLP-1 weight-loss drugs than the state's men, new data shows. Why it matters: This is another cultural moment when women, especially ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

“This study further supports the link between weight loss, in this case with GLP-1 drugs, and improved asthma control,” said Johannes. “It also raises the possibility that GLP-1 drugs may be ...

GLP-1 drugs, such as Ozempic and the combination drug tirzepatide also included in the study, mimic a natural hormone known as glucagon-like peptide-1 to help regulate blood sugar and insulin levels.